Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Kidney cancer

Novel targets in altered tumour metabolism in kidney cancer

Nature Reviews Urology volume 12, pages 428–429 (2015)Cite this article

Subjects

Alterations in metabolism are fundamental to the development and progression of renal cell carcinoma (RCC). Through use of a combined proteomic and metabolomic analysis approach, a new paper enhances our understanding of the metabolomic alterations that occur in RCC and highlights new therapeutic targets.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Key metabolic pathways discussed by Wettersten et al. that can be targeted to treat kidney cancer.

References

  1. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).

  2. Linehan, W. M., Srinivasan, R. & Schmidt, L. S. The genetic basis of kidney cancer: a metabolic disease. Nat. Rev. Urol. 7, 277–285 (2010).

    Article  CAS  Google Scholar 

  3. Hsu, P. P. & Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell 134, 703–707 (2008).

    Article  CAS  Google Scholar 

  4. Wettersten, H. I. et al. Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis. Cancer Res. http://dx.doi.org/10.1158/0008–5472CAN-14-1703 (2015).

  5. Fu, L., Wang, G., Shevchuk, M. M., Nanus, D. M. & Gudas, L. J. Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α. Cancer Res. 71, 6848–6456 (2011).

    Article  CAS  Google Scholar 

  6. Minton, D. R. et al. Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma. PLoS ONE 10, e0120649 (2015).

    Article  Google Scholar 

  7. Wise, D. R. et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc. Natl Acad. Sci. USA 108, 19611–19616 (2011).

    Article  CAS  Google Scholar 

  8. Gameiro, P. A. et al. In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation. Cell Metab. 17, 372–385 (2013).

    Article  CAS  Google Scholar 

  9. Hamanaka, R. B. & Chandel, N. S. Targeting glucose metabolism for cancer therapy. J. Exp. Med. 209, 211–215 (2012).

    Article  CAS  Google Scholar 

  10. Wise, D. R. & Thompson, C. B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35, 427–433 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Weill Cornell Medical College, 1300 York Avenue, New York, 10021, NY, USA

    Denise R. Minton

  2. Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, 1300 York Avenue, New York, 10021, NY, USA

    David M. Nanus

Authors
  1. Denise R. Minton
    View author publications

    Search author on:PubMed Google Scholar

  2. David M. Nanus
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to David M. Nanus.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minton, D., Nanus, D. Novel targets in altered tumour metabolism in kidney cancer. Nat Rev Urol 12, 428–429 (2015). https://doi.org/10.1038/nrurol.2015.168

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrurol.2015.168

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research